OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Preclinical and clinical studies into the bioactivity of low-dose naltrexone (LDN) for oncotherapy
Na Qu, Yiming Meng, Mike Handley, et al.
International Immunopharmacology (2021) Vol. 96, pp. 107714-107714
Closed Access | Times Cited: 10
Na Qu, Yiming Meng, Mike Handley, et al.
International Immunopharmacology (2021) Vol. 96, pp. 107714-107714
Closed Access | Times Cited: 10
Showing 10 citing articles:
Antagonists of the Mu-Opioid Receptor in the Cancer Patient: Fact or Fiction?
Amparo Belltall, Guido Mazzinari, Óscar Díaz‐Cambronero, et al.
Current Oncology Reports (2022) Vol. 24, Iss. 10, pp. 1337-1349
Open Access | Times Cited: 12
Amparo Belltall, Guido Mazzinari, Óscar Díaz‐Cambronero, et al.
Current Oncology Reports (2022) Vol. 24, Iss. 10, pp. 1337-1349
Open Access | Times Cited: 12
Efficacy and Safety of Low Dose Naltrexone for Chronic Pain
Madison N. Irwin, David Cooke, Daniel Berland, et al.
Journal of Pain & Palliative Care Pharmacotherapy (2024) Vol. 38, Iss. 1, pp. 13-19
Closed Access | Times Cited: 2
Madison N. Irwin, David Cooke, Daniel Berland, et al.
Journal of Pain & Palliative Care Pharmacotherapy (2024) Vol. 38, Iss. 1, pp. 13-19
Closed Access | Times Cited: 2
Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy
Marianna Ciwun, Anna Tankiewicz‐Kwedlo, Dariusz Pawlak
Cancers (2024) Vol. 16, Iss. 6, pp. 1240-1240
Open Access | Times Cited: 2
Marianna Ciwun, Anna Tankiewicz‐Kwedlo, Dariusz Pawlak
Cancers (2024) Vol. 16, Iss. 6, pp. 1240-1240
Open Access | Times Cited: 2
Investigation into the restoration of TRPM3 ion channel activity in post-COVID-19 condition: a potential pharmacotherapeutic target
Etianne Martini Sasso, Katsuhiko Muraki, Natalie Eaton-Fitch, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Etianne Martini Sasso, Katsuhiko Muraki, Natalie Eaton-Fitch, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Effects of perioperative low-dose naloxone on the immune system in patients undergoing laparoscopic-assisted total gastrectomy: a randomized controlled trial
Xiangzhen Min, Yan Ma, Yufang Leng, et al.
BMC Anesthesiology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Xiangzhen Min, Yan Ma, Yufang Leng, et al.
BMC Anesthesiology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Potential influence of different peri-operative analgesic regimens on tumour biology and outcome after oncologic surgery
Lucillia Bezu, Patrice Forget, Markus W. Hollmann, et al.
European Journal of Anaesthesiology (2024)
Closed Access | Times Cited: 1
Lucillia Bezu, Patrice Forget, Markus W. Hollmann, et al.
European Journal of Anaesthesiology (2024)
Closed Access | Times Cited: 1
Combination of cannabidiol with low‑dose naltrexone increases the anticancer action of chemotherapy in vitro and in vivo
Wai M. Liu, Nadine Hall, Harry Liu, et al.
Oncology Reports (2022) Vol. 47, Iss. 4
Open Access | Times Cited: 4
Wai M. Liu, Nadine Hall, Harry Liu, et al.
Oncology Reports (2022) Vol. 47, Iss. 4
Open Access | Times Cited: 4
Effects of perioperative low-dose naloxone on the immune system in patients undergoing laparoscopic assisted total gastrectomy: a randomized controlled trial
Xiangzhen Min, Yan Ma, Yufang Leng, et al.
Research Square (Research Square) (2024)
Open Access
Xiangzhen Min, Yan Ma, Yufang Leng, et al.
Research Square (Research Square) (2024)
Open Access
Peptidergic G-Protein-Coupled Receptor Signaling Systems in Cancer: Examination of Receptor Structure and Signaling to Foster Innovative Pharmacological Solutions
Francisco D. Rodríguez, Rafael Coveñas
Future Pharmacology (2024) Vol. 4, Iss. 4, pp. 801-824
Open Access
Francisco D. Rodríguez, Rafael Coveñas
Future Pharmacology (2024) Vol. 4, Iss. 4, pp. 801-824
Open Access
Drugs For Relapse Prevention in Addiction: Review of Psychological and Neurological Factors, Genetics and Neurobiological Mechanisms
Hua Cheng
Frontiers in clinical drug research. CNS and neurological disorders (2023), pp. 158-237
Open Access
Hua Cheng
Frontiers in clinical drug research. CNS and neurological disorders (2023), pp. 158-237
Open Access
